AstraZeneca
AZN · NYSE
Bulios Fair Price
$180.81
15.2% upside
Current Price
$156.91
According to Bulios Fair Price, AZN is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
AstraZeneca (AZN) is a British-Swedish pharmaceutical company specializing in the research, development, and production of drugs for a wide range of therapeutic areas, including oncology, cardiovascular, respiratory, and immunological diseases. The company is known for its emphasis on scientific innovation and global healthcare initiatives, enabling it to bring new treatment options to patients worldwide. AstraZeneca also invests in the development of biologics and personalized medicine to improve treatment efficacy and outcomes. AstraZeneca (AZN) shares could be suitable for investors looking for opportunities in the pharmaceutical sector with a focus on research, innovation, and a broad therapeutic portfolio.
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Pascal Claude Roland Soriot
Employees
96,100
Headquarters
Cambridge
Upcoming events
Earnings
Upcoming earnings report